🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GW842166X is a selective non-cannabinoid CB2 receptor agonist, which is und...
Status
Withdrawn
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT00536497
Treatments Being Tested
This is a double-blind, two-period, placebo controlled cross-over Phase IIa...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-07-06
Trial ID
NCT00479427
The purpose of this study is to assess the dose response and efficacy of si...
Status
Withdrawn
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00554762
Treatments Being Tested
The purpose of this study is to determine whether GW842166 is effective in ...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-04
Trial ID
NCT00447486
Treatments Being Tested
This phase IIa (proof of concept) study will be conducted as a multi-centre...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-10
Trial ID
NCT00444769
Treatments Being Tested
GW842166X is being developed for the treatment and management of inflammato...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-06-26
Trial ID
NCT00511524
Treatments Being Tested